Loading...

ImmuPharma plc

ALIMM.BR•EURONEXT
Healthcare
Biotechnology
€0.09
€0.00(0.00%)

ImmuPharma plc (ALIMM.BR) Stock Overview

Explore ImmuPharma plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 61.5/100

Key Financials

Market Cap0
P/E Ratio-2.27
EPS (TTM)$-0.04
ROE-0.92%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

ALIMM.BR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of ImmuPharma plc (ALIMM.BR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.27 and a market capitalization of 0. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;